A single session improved symptoms in combat veterans ...

The VA recently announced funding for a new study on MDMA-assisted therapy for veterans with PTSD and alcohol use disorder.

MIAMI – The lack of progress in development of drugs to effectively treat posttraumatic stress disorder (PTSD) has become a "crisis" and has led to a significant shift in the US Department of Veterans ...

No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or ...

The drug is currently classified as a Schedule I controlled substance in the United States, leading those seeking treatment to seek care out of the country.

COLUMBUS, Ohio (WCMH) — Ohio lawmakers heard emotional testimony this week from several veterans, each describing how ...

SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery ...

An experimental drug reverses PTSD-like symptoms in mice. The corresponding study was published in Signal Transduction and Targeted Therapy and may pave the way for a new treatment for PTSD. “This ...

Researchers are discovering that post-traumatic stress disorder (PTSD) is a significant risk factor in developing dementia. Dementia is a memory problem that affects a person's ability to carry out ...

The Chief of Army Staff, Lieutenant General Waidi Shaibu, has declared that a strong warrior ethos remains the bedrock of combat readiness, unit cohesion, and operational success of the Nigerian Army, ...

Only two drugs are currently approved by the FDA for treating PTSD, both of which primarily target the depressive effects of the condition. In contrast, SPC-15’s differentiated method of action is ...